AccessPak for HIV PEP Expanded with Kaletra and Olopatadine nasal
Determining the interaction of AccessPak for HIV PEP Expanded with Kaletra and Olopatadine nasal and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: emtricitabine / lopinavir / ritonavir / tenofovir
Brand name: AccessPak for HIV PEP Expanded with Kaletra
Synonyms: n.a.
Generic Name: olopatadine nasal
Brand name: Patanase
Synonyms: Olopatadine (nasal), Olopatadine (Nasal)
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- AccessPak for HIV PEP Expanded with Kaletra-Olopatadine Nasal Spray
- AccessPak for HIV PEP Expanded with Kaletra-Olsalazine
- AccessPak for HIV PEP Expanded with Kaletra-Olsalazine Sodium
- AccessPak for HIV PEP Expanded with Kaletra-Olumiant
- AccessPak for HIV PEP Expanded with Kaletra-Olux
- AccessPak for HIV PEP Expanded with Kaletra-Olux-E
- Olopatadine nasal-AccessPak for HIV PEP Expanded with Viracept
- Olopatadine nasal-Accolate
- Olopatadine nasal-Accretropin
- Olopatadine nasal-Accucaine
- Olopatadine nasal-AccuHist Drops
- Olopatadine nasal-AccuHist PDX Drops